October 8, 2024

X-ray Systems Market Size to Reach US$ 9.6 billion by 2030

The global X-ray systems market size was valued at USD 5.7 billion in 2020, and is predicted to be worth around USD 9.6 billion by 2030, registering a CAGR of 2.4% during the forecast period 2022 to 2030.

X-ray systems Market (By Modality: Radiography, Fluoroscopy, Mammography; By Technology: Digital Radiography, Computed Radiography; By Mobility: Stationary, Mobile; By End-use: Hospitals, Diagnostic imaging centres) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39115

Report Coverage

Report ScopeDetails
Market SizeUS$ 9.6 billion by 2030
Growth RateCAGR of 2.4% From 2022 to 2030
Largest MarketNorth America
Base Year2021
Forecast Period2022 to 2030
Segments CoveredModality, Technology, Mobility, End use

Growth Factors

Technological advancements in the healthcare sector and supportive investments by the government are driving the market. In addition, increase in the demand for early-stage diagnosis of chronic diseases and screening programs are expected to boost market growth.

Emerging innovations in the x-ray systems is expanding the market size, such as integration of Artificial Intelligence (AI) in medical imaging systems, robotic, and mobile x-ray systems have made the technology more accessible for use in limited-resource communities around the world. For instance, in March 2021, Philips healthcare announced partnership with Lunit, a leading medical AI startup, with this collaboration Lunit’s INSIGHT CXR chest detection suite will be incorporated into Philips diagnostic x-ray suite, to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.

The COVID-19 pandemic has posed challenges and changed healthcare systems globally. Radiology has considerably improved patient care in this crisis, owing to rapid advancements.The first imaging procedure that played an important role in the treatment of COVID-19 was chest radiography, since it plays a major role in the diagnosis of COVID-19. 

Key Players

  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • GE Healthcare
  • Canon Medical Systems
  • Shimadzu Corporation
  • FUJIFILM SonoSite, Inc.
  • Carestream
  • Mindray Medical International Limited
  • Hologic, Inc
  • New Medical Imaging
  • AGFA

Market Segmentation

  • By Modality
    • Radiography
    • Fluoroscopy
    • Mammography
  • By Technology
    • Digital radiography
    • Computed radiography
  • By Mobility
    • Stationary
    • Mobile
  • By End-use
    • Hospitals
    • Diagnostic imaging centres
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39115

Reasons to Purchase this Report:– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2019-2021) and forecast (2022-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Mobility Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global X-ray Systems Market, By Modality

7.1.  X-ray Systems Market, by Modality, 2021-2030

7.1.1.    Radiography

7.1.1.1.        Market Revenue and Forecast (2019-2030)

7.1.2.    Fluoroscopy

7.1.2.1.        Market Revenue and Forecast (2019-2030)

7.1.3.    Mammography

7.1.3.1.        Market Revenue and Forecast (2019-2030)

Chapter 8.  Global X-ray Systems Market, By Technology

8.1.  X-ray Systems Market, by Technology, 2021-2030

8.1.1.    Digital Radiography

8.1.1.1.        Market Revenue and Forecast (2019-2030)

8.1.2.    Computed Radiography

8.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 9.  Global X-ray Systems Market, By Mobility

9.1.  X-ray Systems Market, by Mobility, 2021-2030

9.1.1.    Stationary

9.1.1.1.        Market Revenue and Forecast (2019-2030)

9.1.2.    Mobile

9.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 10.      Global X-ray Systems Market, By End-use

10.1.        X-ray Systems Market, by End-use, 2021-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2019-2030)

10.1.2.  Diagnostic imaging centres

10.1.2.1.      Market Revenue and Forecast (2019-2030)

Chapter 11.      Global X-ray Systems Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Modality (2019-2030)

11.1.2.  Market Revenue and Forecast, by Technology (2019-2030)

11.1.3.  Market Revenue and Forecast, by Mobility (2019-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.1.5.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.1.5.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.1.6.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.1.6.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Modality (2019-2030)

11.2.2.  Market Revenue and Forecast, by Technology (2019-2030)

11.2.3.  Market Revenue and Forecast, by Mobility (2019-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.2.5.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.2.5.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.2.6.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.2.6.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.2.7.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.2.7.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.2.8.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.2.8.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Modality (2019-2030)

11.3.2.  Market Revenue and Forecast, by Technology (2019-2030)

11.3.3.  Market Revenue and Forecast, by Mobility (2019-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.3.5.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.3.5.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.3.6.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.3.6.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.3.7.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.3.7.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.3.8.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.3.8.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Modality (2019-2030)

11.4.2.  Market Revenue and Forecast, by Technology (2019-2030)

11.4.3.  Market Revenue and Forecast, by Mobility (2019-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.4.5.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.4.5.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.4.6.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.4.6.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.4.7.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.4.7.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.4.8.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.4.8.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Modality (2019-2030)

11.5.2.  Market Revenue and Forecast, by Technology (2019-2030)

11.5.3.  Market Revenue and Forecast, by Mobility (2019-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.5.5.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.5.5.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Modality (2019-2030)

11.5.6.2.      Market Revenue and Forecast, by Technology (2019-2030)

11.5.6.3.      Market Revenue and Forecast, by Mobility (2019-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

Chapter 12.  Company Profiles

12.1.              Koninklijke Philips N.V.

12.1.1.  Company Overview

12.1.2.  Modality Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Siemens Healthineers AG

12.2.1.  Company Overview

12.2.2.  Modality Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              GE Healthcare

12.3.1.  Company Overview

12.3.2.  Modality Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Canon Medical Systems

12.4.1.  Company Overview

12.4.2.  Modality Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Shimadzu Corporation

12.5.1.  Company Overview

12.5.2.  Modality Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              FUJIFILM SonoSite, Inc.

12.6.1.  Company Overview

12.6.2.  Modality Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Carestream

12.7.1.  Company Overview

12.7.2.  Modality Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Mindray Medical International Limited

12.8.1.  Company Overview

12.8.2.  Modality Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Hologic, Inc

12.9.1.  Company Overview

12.9.2.  Modality Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           New Medical Imaging

12.10.1.               Company Overview

12.10.2.               Modality Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39115

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →